start portlet menu bar

Visualizador de conteúdo da Web

Display portlet menu
end portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Página inicial Conhecimento Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

European Sea Bass (Dicentrarchus labrax) is a marine fish species with a high commercial value, especially in the Mediterranean countries and Europe. Vibriosis caused by Listonella (Vibrio) anguillarum is a common disease in Sea Bass that has led to significant economic losses to date. Therefore, development and use of preventive strategies can evade these associated mortalities [1].

Transferir este artigo

4,75 MB

Acerca deste artigo

Autores

Ruiz, M. C.; Robles, R.; Callol, C.; Colomer, S.; Vendrell, D.; Perelló, M. Bermúdez, L.

Sumário

Clear differences in the mortality rates between vaccinated and control groups were observed. The mortality rates reported in vaccinated groups ranged between 21.67 and 22.22 % whereas the mortality rates in control groups were of 60-97.78 %. Deaths were observed between 24 and 72 hours after challenge.

Serviços relacionados

HIPRA Diagnos

Produtos relacionados

ICTHIOVAC® VR

Publicações relacionadas

Safety and efficacy of an inactivated vaccine against Lactococcus garvieae in rainbow trout (Oncorhynchus mykiss) Lactococcus garvieae in fish: A review

Partilhar

start portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Display portlet menu
end portlet menu bar

Consulte também

Publicações

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O1 in European sea bass f...

02-06-2016
Resumos de doenças

Lactococcosis in trout

12-01-2017
Novidades

HIPRA presents ICTHIOVAC® VR/PD vaccine in Greece

27-03-2018